LDR | |
00923nam a2200241 i 4500 |
001 |
|
010998953 |
003 |
|
MiAaHDL |
005 |
|
20110502000000.0 |
006 |
|
m d |
007 |
|
cr bn ---auaua |
008 |
|
790219s1973 mdu f00010 eng d |
035 |
⊔ |
⊔ |
‡asdr-chi259043
|
035 |
⊔ |
⊔ |
‡a(OCoLC)28775946
|
035 |
⊔ |
⊔ |
‡a(ICU)BID3799616
|
040 |
⊔ |
⊔ |
‡aICU
‡cICU
|
041 |
0 |
⊔ |
‡aeng
|
100 |
1 |
⊔ |
‡aMcGlashan, Thomas H.,
‡d1941-
|
245 |
1 |
4 |
‡aThe documentation of clinical psychotropic drug trails /
‡c[edited by Thomas McGlashan].
|
260 |
0 |
⊔ |
‡aRockville, Md. :
‡bNational Institute of Mental Health,
‡c1973.
|
300 |
⊔ |
⊔ |
‡a2 v. ;
‡c27 cm.
|
500 |
⊔ |
⊔ |
‡aOn cover of v.[2]: Early clinical drug evaluation units, analyses. Sample output package.
|
538 |
⊔ |
⊔ |
‡aMode of access: Internet.
|
650 |
⊔ |
0 |
‡aDrugs
‡xTesting
|
650 |
⊔ |
0 |
‡aPsychopharmacology
|
710 |
2 |
0 |
‡aNational Institute of Mental Health (U.S.)
|
830 |
⊔ |
0 |
‡aDHEW publication
‡vno. (HSM) 73-9038--73-9039.
|
CID |
⊔ |
⊔ |
‡a010998953
|
DAT |
0 |
⊔ |
‡a19950829000000.0
‡b20110502000000.0
|
DAT |
1 |
⊔ |
‡a20120814082529.0
‡b2023-06-24T17:30:04Z
|
CAT |
⊔ |
⊔ |
‡aSDR-CHI
‡dUNKNOWN
‡lloader.pl-001-001
|
FMT |
⊔ |
⊔ |
‡aBK
|
HOL |
⊔ |
⊔ |
‡0sdr-chi259043
‡achi
‡bSDR
‡cCHI
‡pchi.17856434
‡sCHI
‡zc.1 v.2
‡1259043
|
974 |
⊔ |
⊔ |
‡bCHI
‡cCHI
‡d20230624
‡sgoogle
‡uchi.17856434
‡zc.1 v.2
‡y1973
‡rpd
‡qbib
‡tUS fed doc
|
974 |
⊔ |
⊔ |
‡bCHI
‡cCHI
‡d20240811
‡sgoogle
‡uchi.29809427
‡zc.1 v.1
‡y1973
‡rpd
‡qbib
‡tUS fed doc
|